drugset / Trial / NCT02737397

Safety and Efficacy of a Combination Product for the Prevention of Veisalgia

NCT02737397 ↗

Phase 2 Completed 13 enrolled Sen-Jam Pharmaceutical
RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to determine the safety and efficacy of a combination product for the prevention of veisalgia. Common symptoms of veisalgia following the moderate consumption of alcohol includes headache, fatigue, and thirst. It is the investigators hypothesis that a combination of two drugs can alleviate or significantly reduce these symptoms when taken before the start of moderate alcohol consumption.

Timeline

Start
2016-03
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject SJP-223 Unknown — —
Subject SJP-304 Unknown — —

Indications

No indication recorded.